HIGHLIGHTS
- who: Tina A. Kituashvili and collaborators from the , have published the research: Efficacy of Lazolex Gel in the Treatment of Herpes Simplex Mucocutaneous Infections and the Prevention of Recurrences: A Pilot Study, in the Journal: Canadian Journal of Infectious Diseases and Medical Microbiology of 16/Nov/2022
- what: Topical treatment with Lazolex Gel applied to lesions four times a day for 10 days has proven to be efective and safe to treat mucocutaneous lesions caused by HSV-1 and HSV-2 and to reduce the frequency of recurrence.
- future: Tis combination was more . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.